BGN and lupus nephritis: Plasma biglycan levels increased in patients with diabetic nephropathy, lupus nephritis, and in those with acute renal allograft rejection, and correlated with increased levels of the pro‐inflammatory chemokines/cytokines RANTES, IL‐1β, TNF‐α, MCP‐1 and CXCL13 [158].